Primary immunodeficiency: common variable immunodeficiency

Первичный иммунодефицит: общая вариабельная иммунная недостаточность
Oksana Ussenova 1, Dinara Gabdullina 1, Marina Morenko 1, Yelena Kovzel 2
More Detail
1 Astana Medical University, Department of children’s diseases №1, Astana, Kazakhstan
2 Republican Diagnostic Center, Department of Allergology, pulmonology and orphan diseases, Astana, Kazakhstan
J CLIN MED KAZ, Volume 1, Issue 39, pp. 16-19.
OPEN ACCESS 3630 Views 2816 Downloads
Download Full Text (PDF)


By definition, primary immunodeficiencies are genetically determined diseases, which are fundamental molecular or organic defects associated with impaired immune responses, in this case there is the clinic of infectious and autoimmune diseases, with an increased risk of developing malignancies. Primary immunodeficiency diseases more frequent than previously thought. The lack of clear algorithms and the use of outdated technologies considerably delay diagnosis process, which leads to delays expensive no specific treatment instead of Immunotropic effective therapy. The first episodes of primary immunodeficiencies (PID) are manifested at an early age, but also the primary PID can also occur in adults, the first episode of the disease observed in the 20-30 years of age.


Ussenova O, Gabdullina D, Morenko M, Kovzel Y. Primary immunodeficiency: common variable immunodeficiency. Journal of Clinical Medicine of Kazakhstan. 2016;1(39):16-9.


  • Al-Herz W., Notarangelo D.L. Classification of primary immunodeficiency disorders: One-fits-all does not help anymore, Clinical Immunology, 2012, Vol. 144, pp. 24-25.
  • Slabkaja E.V., Aksenova S.A., Barsukova V.V., Meshkova R.Ja. Sozdanie registra pervichnyh immunodeficitov Smolenskoj oblasti (Creating a registry of primary immunodeficiencies Smolensk region), Allergologija i immunologija v pediatrii, 2012, No.4, pp. 25-28.
  • Pishalnokov A.Y., Moiseeva T.N. Analiz dinamiki osnovnih fenotipicheskih proyavlenii immunnoi nedostatochnosti u pacientov s pervichnimi immunodecitami po rezultatam mnogoletnego nablyudeniya, Vestnik YuUrGU, 2009, No.20, pp. 100- 105.
  • Tuzakina I.A., Karakina M.L., Vlasova E.V. Analiz klinicheskih projavlenii debjuta pervichnyh immunodeficitov u vzroslyh (Analysis of clinical manifestations of primary immunodeficiencies debut in adults), Medicinskaja immunologija, 2014, Vol. 16, No. 4, pp. 367-374.
  • Sibgatullina F.I., Fathullina R.S. Pervichnie immunodeficiti u detei v Respublike Tatarstan, 2009.
  • Luncov A.V., Skorohodkina O.V., Nurhametova D.F. Infekcionnyi sindrom u bolnyh s pervichnymi immunodeficitami i vozmozhnosti ego korekcii (Infectious syndrome in patients with primary immunodeficiencies and possibilities of its correction), Prakticheskaja medicina, 2015, Vol. 2, No. 4, pp. 72-75.
  • Otarbaev N.K., Kovzel E.F. Pervichnye immunodeficity (Primary immunodeficiencies), Metodicheskie recomendacii, 2014, pp. 5-15.
  • Kovzel E.F., Rozenson R.I., Morenko M.A. Pervichnie immunodeficiti v Respublike Kazahstan, Vestnik AGIUV, 2013, pp. 103-105.
  • De Vryz E. Mnogostupenchatyi diagnosticheskii protokol skriniga pacientov na nalichie pervichnogo immunodeficita, razrabotannyj dlja vrachej-neimmunologov (Multistage diagnostic protocol screening patients for the presence of primary immunodeficiency, designed for doctors not an immunologist), Medicinskaja immunologija, 2013, Vol. 15, No. 5, pp. 477-492.
  • Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand, J Clin Immunol, 2007, No.27, pр.517–524.
  • Rhim J.W., Kim K.H., Kim D.S., et al. Prevalence of primary immunodeficiency in Korea, J Korean Med Sci, 2012, No.27, pр.788–793.
  • Ishimura M., Takada H., Doi T. et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan, J Clin Immunol, 2011, No.31, рp.968–976.
  • Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients, Clin Immunol, 2011, No.92, pр.34–48.
  • Vorechovsky I., Zetterquist H., Paganelli R. et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency, Clin. Immunol. Immunopathol, 2005, No.77, pр.185–192.
  • Burrows P.D., Cooper M.D. IgA deficiency, Adv. Immunol, 2007, No.65, pр.245–276.
  • Park J.H., Resnick E.S., Cunningham-Rundles C. Perspectives on common variable immune deficiency, Ann NY Acad Sci, 2011, No.1246, pр.41–49.
  • van Zelm M.C., Reisli I., van der Burg M. et al. An antibody-deficiency syndrome due to mutations in the CD19 gene, N. Engl J Med, 2006, No.354, pр.1901–1912.
  • Grimbacher B., Hutloff A., Schlesier M. et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency, Nat Immunol, 2003, No.4, pр.261–268.
  • Kuijpers T.W., Bende R.J., Baars P.A. et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses, J Clin Invest, 2010, No.120, pр.214–222.
  • van Zelm M.C., Smet J., Adams B. et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody, J Clin Invest, 2010, No.120, pр.1265–1274.
  • Al-Herz W., Bousfiha A., Casanova J.L. et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency, Front. Immunol, 2011, No.2, р.54
  • Pan-Hammarstrom Q., Salzer U., Du L. et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency, Nat Genet, 2007, No.39, pр.429–430.
  • Sekine H., Ferreira R.C., Pan-Hammarstrom Q. et al. Role for Msh5 in the regulation of Ig class switch recombination, Proc. Natl. Acad Sci USA, 2007, No.104, pр.7193–7198.
  • Koopmans W., Woon S.T., Brooks A.E., Dunbar P.R., Browett P., Ameratunga R. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), J Clin Immunol, 2013, No.33, pр.68–73.
  • Chapel H., Lucas M., Lee M. et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes, Blood, 2008, No.112, pр.277–286.
  • Conley M.E., Dobbs A.K., Farmer D.M. et al. Primary B cell immunodeficiencies: comparisons and contrasts, Annu. Rev. Immunol, 2009, No.27, pр.199–227.
  • Cunningham-Rundles C. Common variable immunodeficiency, Curr. Allergy Asthma Rep, 2001, No.1, pр.421–429.
  • Notarangelo L.D., Fischer A., Geha R.S. et al. Primary immunodeficiencies: 2009 update, J. Allergy Clin. Immunol, 2009, No.124, pр.1161–1178.
  • Chapel H., Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions, Br. J. Haematol, 2009, No.145, pp.709–727.
  • Hutloff A., Dittrich A.M., Beier K.C. et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28, Nature, 2009, No.397, рp. 263–266.
  • Grimbacher B., Hutloff A., Schlesier M. et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency, Nat. Immunol., 2003, No.4, pр.261–268.
  • Carter R.H., Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes, Science, 2012, No.256, pр.105–107.
  • van Zelm M.C., Reisli I., van der Burg M. et al. An antibody-deficiency syndrome due to mutations in the CD19 gene, N. Engl. J. Med., 2006, No.354, рp.1901–1912.
  • Stashenko P., Nadler L.M., Hardy R., Schlossman S.F. Characterization of a human B lymphocyte-specific antigen, J. Immunol., 2013, No.125, pр.1678–1685.
  • Kuijpers T.W., Bende R.J., Baars P.A. et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses, J. Clin. Invest, 2010, No.120, pр.214–222.
  • Mackay F., Schneider P., Rennert P., Browning J. BAFF AND APRIL: a tutorial on B cell survival, Annu. Rev. Immunol, 2003, No.21, pр.231–264.
  • Ng L.G., Sutherland A.P., Newton R. et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells, J. Immunol, 2004, No.173, pр.807–817.
  • Batten M., Groom J., Cachero T.G. et al. BAFF mediates survival of peripheral immature B lymphocytes, J. Exp. Med., 2000, No.192, pр.1453–1466.
  • Gross J.A., Dillon S.R., Mudri S. et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS, Immunity, 2001, No.15, pр. 289–302.
  • Sasaki Y., Casola S., Kutok J.L. et al. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology, J. Immunol., 2004, No.173, pр.2245–2252.
  • Schiemann B., Gommerman J.L., Vora K. et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway, Science, 2001, No.293, pр.2111–2114.
  • Shulga-Morskaya S., Dobles M., Walsh M.E. et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation, J. Immunol, 2004, No.173, рp.2331–2341.
  • Yan M., Brady J.R., Chan B. et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency, Curr. Biol., 2001, No.11, pр.1547–1552.
  • Warnatz K., Salzer U., Rizzi M. et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans, Proc. Natl. Acad. Sci. USA, 2009, No.106, pр.13945–13950.
  • Washington K., Stenzel T.T., Buckley R.H. et al. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia, Am J Surg Pathol, 2009, No.20, pр.1240–1252.
  • Kalha I., Sellin J.H. Common variable immunodeficiency and the gastrointestinal tract, Curr Gastroenterol Rep, 2004, No.6, pр.377–383.
  • Hermans P.E., Diaz-Buxo J.A., Stobo J.D. Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients, Am J Med, 2008, No.61, рp.221–237.
  • Hermaszewski R.A., Webster A.D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications, Q J Med., 2013, No.86, pр.31–42.